Table 1.
Clinical and tumour characteristics in patients with advanced pancreatic head adenocarcinoma (n = 111)
| SURG group (n = 72) | CRT group (n = 39) | P-valueb | |
|---|---|---|---|
| n (%) | n (%) | ||
| Age | 0.002 | ||
| ≤65 years | 28 (38.9) | 27 (69.2) | |
| >65 years | 44 (61.1) | 12 (30.8) | |
| Sex | 0.059 | ||
| Male | 43 (59.7) | 16 (41.0) | |
| Female | 29 (40.3) | 23 (59.0) | |
| Body mass index, kg/m2a | 0.966 | ||
| ≤23 kg/m2 | 26 (53.1) | 15 (53.6) | |
| >23 kg/m2 | 23 (46.9) | 13 (46.4) | |
| ASA scorea | 0.758 | ||
| 1 | 20 (27.8) | 13 (33.3) | |
| 2 | 44 (61.1) | 21 (53.8) | |
| 3 | 8 (11.1) | 5 (12.8) | |
| Preoperative status | |||
| Tumour statusa | <0.001 | ||
| T1 | 29 (41.4) | 1 (2.6) | |
| T2 | 32 (45.7) | 0 | |
| T3 | 9 (12.9) | 14 (35.9) | |
| T4 | 0 | 24 (61.5) | |
| Nodal status | 0.001 | ||
| N− | 61 (88.4) | 20 (58.8) | |
| N+ | 8 (11.6) | 14 (41.2) | |
| Vein involvementa | <0.001 | ||
| Yes | 8 (11.6) | 24 (64.9) | |
| No | 61 (88.4) | 13 (35.1) | |
| Artery involvementa | <0.001 | ||
| Yes | 0 | 22 (59.5) | |
| No | 69 (100) | 15 (40.5) | |
| Postoperative status | |||
| Tumour statusa | <0.001 | ||
| T0 | 0 | 5 (12.8) | |
| T1 | 29 (41.4) | 3 (7.7) | |
| T2 | 32 (45.7) | 4 (10.3) | |
| T3 | 9 (12.9) | 27 (69.2) | |
| T4 | 0 | 0 | |
| Resection type | 0.240 | ||
| R0 | 54 (75.0) | 33 (84.6) | |
| R1 | 18 (25.0) | 6 (15.4) | |
| Vascular/lymphatic emboli | 0.001 | ||
| Yes | 32 (55.2) | 7 (20.0) | |
| No | 26 (44.8) | 28 (80.0) | |
| Perineural invasiona | 0.065 | ||
| Yes | 40 (70.2) | 19 (51.4) | |
| No | 17 (29.8) | 18 (48.6) | |
| Nodal status | <0.001 | ||
| N− | 16 (22.2) | 23 (59.0) | |
| N+ | 56 (77.8) | 16 (41.0) |
a
Missing data.
b
P-values in bold are significant at P ≤ 0.01.
SURG group, surgery-only group; CRT group, preoperative chemoradiotherapy group; ASA, American Society of Anesthesiologists.